Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT

Radiology

Volumn 264, Issue 3, 2012, Pages 876-883

  Nacif, Marcelo Souto ^a,b   Kawel, Nadine ^a   Lee, Jason J ^a   Chen, Xinjian ^a   Yao, Jianhua ^a   Zavodni, Anna ^a   Sibley, Christopher T ^a,b,c   Lima, João A C ^b   Liu, Songtao ^a,c   Bluemke, David A ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; IOPAMIDOL;

AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXTRACELLULAR SPACE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE FIBROSIS; HUMAN; MALE; PRIORITY JOURNAL; RADIATION DOSE; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; CARDIAC-GATED IMAGING TECHNIQUES; CONTRAST MEDIA; ENDOMYOCARDIAL FIBROSIS; FEMALE; FIBROSIS; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIATION DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84865441385     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12112458     Document Type: Article

References (31)

1. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100(19):1992-2002.
2. Senra T, Shiozaki AA, Salemi VM, Rochitte CE. Delayed enhancement by multidetector computed tomography in endomyocardial fibrosis. Eur Heart J 2008;29(3):347.
3. Bauer RW, Kerl JM, Fischer N, et al. Dualenergy CT for the assessment of chronic myocardial infarction in patients with chronic coronary artery disease: comparison with 3-T MRI. AJR Am J Roentgenol 2010;195(3):639-646.
4. Lardo AC, Cordeiro MA, Silva C, et al. Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation 2006;113(3):394-404.
5. Schuleri KH, Centola M, George RT, et al. Characterization of peri-infarct zone heterogeneity by contrast-enhanced multidetector computed tomography: a comparison with magnetic resonance imaging. J Am Coll Cardiol 2009;53(18):1699-1707.
6. Siemers PT, Higgins CB, Schmidt W, Ashburn W, Hagan P. Detection, quantitation and contrast enhancement of myocardial infarction utilizing computerized axial tomography: comparison with histochemical staining and 99mTc-pyrophosphate imaging. Invest Radiol 1978;13(2):103-109.
7. Messroghli DR, Walters K, Plein S, et al. Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med 2007;58(1):34-40.
8. Friedrich MG. There is more than shape and function. J Am Coll Cardiol 2008;52(19):1581-1583.
9. Iles L, Pfluger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008;52(19):1574-1580.
10. Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010;122(2):138-144.
11. Sibley C, Huang J, Ugander M, et al. Myocardial and blood T1 quantification in normal volunteers at 3T. J Cardiovasc Magn Reson 2011;13(Suppl 1):P51.
12. Sparrow P, Messroghli DR, Reid S, Ridgway JP, Bainbridge G, Sivananthan MU. Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. AJR Am J Roentgenol 2006;187(6):W630-W635.
13. Schelbert EB, Testa SM, Meier CG, et al. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson 2011 Mar 4;13:16.
14. Nacif MS, Kawel N, Sibley CT, Zavodni A, Lima JA, Bluemke DA. Which is your diagnosis? [in Portuguese]. Radiol Bras 2011;44(2):XI-XIII.
15. Nacif MS, Noureldin RA, Sibley CT, Turkbey EB, Lima JA, Bluemke DA. Which is your diagnosis? [in Portuguese]. Radiol Bras 2010;43(5):XI-XIII.
16. Han Y, Peters DC, Dokhan B, Manning WJ. Shorter difference between myocardium and blood optimal inversion time suggests diffuse fibrosis in dilated cardiomyopathy. J Magn Reson Imaging 2009;30(5):967-972.
17. Amano Y, Takayama M, Kumita S. Contrast-enhanced myocardial T1-weighted scout (Look-Locker) imaging for the detection of myocardial damages in hypertrophic cardiomyopathy. J Magn Reson Imaging 2009;30(4):778-784.
18. Jerosch-Herold M, Sheridan DC, Kushner JD, et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;295(3):H1234-H1242.
19. Kehr E, Sono M, Chugh SS, Jerosch-Herold M. Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging 2008;24(1):61-68.
20. Lee JJ, Liu S, Nacif MS, et al. Myocardial T1 and extracellular volume fraction mapping at 3 tesla. J Cardiovasc Magn Reson 2011;13(1):75.
21. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002;47(2):372-383.
22. van der Bijl N, de Bruin PW, Geleijns J, et al. Assessment of coronary artery calcium by using volumetric 320-row multi-detector computed tomography: comparison of 0.5 mm with 3.0 mm slice reconstructions. Int J Cardiovasc Imaging 2010;26(4):473-482.
23. Messroghli DR, Rudolph A, Abdel-Aty H, et al. An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging. BMC Med Imaging 2010;10:16.
24. Diesbourg LD, Prato FS, Wisenberg G, et al. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease.Magn Reson Med 1992;23(2):239-253.
25. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: potential mechanisms. Circulation 1995;92(5):1117-1125.
26. Arheden H, Saeed M, Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echoplanar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 1999;211(3):698-708.
27. Young AA, Cowan BR, Thrupp SF, Hedley WJ, Dell'Italia LJ. Left ventricular mass and volume: fast calculation with guidepoint modeling on MR images. Radiology 2000;216(2):597-602.
28. Budoff MJ, Nasir K, McClelland RL, et al. Coronary calcium predicts events better with absolute calcium scores than age-sexrace/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2009;53(4):345-352.
29. Ugander M, Oki AJ, Hsu LY, et al. Abstract 12126: myocardial extracellular volume imaging by MRI quantitatively characterizes myocardial infarction and subclinical myocardial fibrosis. Circulation 2010;122(21- MeetingAbstracts):A12126.
30. Messroghli DR, Walters K, Plein S, et al. Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med 2007;58(1):34-40.
31. Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R, Friedrich MG. T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2003;5(2):353-359.